ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750035; 2) Community: the network communities that were significantly associated with the response to NSC 750035; 3) Molecule: the relationships between components within communities and NSC 750035; 4) MDR: the compounds that were significantly associated with the NSC 750035.

NSC Compound Enrichment Correlation
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.00385572727186006 0.60900546
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0038671642008129 0.33471847
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0038671642008129 0.31024556
NSC 659936 Null 0.0038671642008129 0.51590518
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.0038671642008129 0.53757429
NSC 666113 Null 0.0038671642008129 0.47533595
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0038671642008129 0.5412963
NSC 710779 Null 0.0038671642008129 0.48695135
NSC 759322 MEVASTATIN 0.0038671642008129 -0.25967763
NSC 79304 Null 0.0038671642008129 0.55161103
Total:108  Current:13    [First] [Prev] [Next] [Last]